[Clotrimazol therapy of skin mycoses]. 1977

H Szarmach, and H Poniecka, and L Stepka

Clinical evaluation of a 1% clotrimazole cream and solution on 236 in and out patients with different clinical manifestations of mycotic infections was done. Clotrimazole, both cream and solution, is an effective and well tolerated agent in the treatment of infections due to dermatophytes and yeasts. Best results were recorded with patients suffering from pityriasis versicolor and erythrasma, and interdigital erosion.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002179 Candidiasis, Cutaneous Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed) Moniliasis, Cutaneous
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003022 Clotrimazole An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. Bay b 5097,Canesten,FB b 5097,Kanesten,Klotrimazole,Lotrimin,Mycelex
D003881 Dermatomycoses Superficial infections of the skin or its appendages by any of various fungi. Skin Diseases, Fungal,Dermatomycosis,Dermatophyte Infection,Fungal Skin Diseases
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004894 Erythrasma A chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum.

Related Publications

H Szarmach, and H Poniecka, and L Stepka
January 1977, Wiener medizinische Wochenschrift (1946),
H Szarmach, and H Poniecka, and L Stepka
May 1973, Medizinische Klinik,
H Szarmach, and H Poniecka, and L Stepka
January 1976, Ginekologia polska,
H Szarmach, and H Poniecka, and L Stepka
November 1973, Zeitschrift fur Hautkrankheiten,
H Szarmach, and H Poniecka, and L Stepka
January 1989, Zeitschrift fur arztliche Fortbildung,
H Szarmach, and H Poniecka, and L Stepka
January 2017, MMW Fortschritte der Medizin,
H Szarmach, and H Poniecka, and L Stepka
January 1991, Annales de dermatologie et de venereologie,
H Szarmach, and H Poniecka, and L Stepka
October 1981, ZFA. Zeitschrift fur Allgemeinmedizin,
H Szarmach, and H Poniecka, and L Stepka
April 1974, Arzneimittel-Forschung,
H Szarmach, and H Poniecka, and L Stepka
February 1996, Fortschritte der Medizin,
Copied contents to your clipboard!